Hepatology

Top Story

OS comparable between Dovitinib, Nexavar for advanced HCC

May 27, 2016

The overall survival and safety rates were similar between patients with advanced hepatocellular carcinoma treated with Dovitinib vs. Nexavar, according to published findings.

“In this randomized phase 2 study, Dovitinib activity was not greater than that of sorafenib as frontline therapy in Asian-Pacific patients with advanced [hepatocellular carcinoma],” Ann-Lii Cheng, MD, PhD, of the National Taiwan University Hospital and National Taiwan University Cancer Center, and colleagues wrote.

Video

VIDEO: Patients with HIV, HCV face risk for re-infection following antiviral treatment

May 27, 2016
Hepatitis C virus re-infection is “an enormous issue” in patients with HIV who are treated, and cured, with direct-acting antivirals, according to Vincent
Drug Pipeline

EMA panel recommends approval of Epclusa for all HCV genotypes

May 27, 2016
The European Committee for Medicinal Products for Human Use granted a positive opinion for Gilead Science’s Marketing Authorization Application for Epclusa for the…
Meeting News Coverage

Cost per SVR with Harvoni lower than previously utilized regimens

May 26, 2016
SAN DIEGO — Researchers determined that the cost per sustained virologic response with Harvoni for treating chronic hepatitis C genotype 1 was much lower than the…
Meeting News CoverageVideo

VIDEO: Outgoing AGA president recaps presidential address at DDW

May 26, 2016
SAN DIEGO — In this exclusive video from DDW 2016, outgoing AGA President Michael Camilleri, MD, from the Mayo Clinic in Rochester, Minn., discusses the major…
More News Headlines »
CME

Rapid Response from Barcelona: New Data in HCV Treatment

This activity is supported by an educational grant from AbbVie and Merck & Co., Inc.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
Video
Meeting News Coverage

ABT-493, ABT-530 produce high SVR rates in HCV genotype 3

April 16, 2016
More »
Featured
Highlights from International Liver Congress

Highlights from International Liver Congress

Current Issues Current Issues
View the Current Issue
HCV Next
morganatic-roan